© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Lexaria Bioscience Corp. (LEXX) shows an Average True Range (ATR) of 0.13 and an Enterprise Value of 25.43M. Its average trading volume over the past 3 months is 516.11K, indicating liquidity. These fundamental metrics provide insight into LEXX's underlying financial health and market activity.
Lexaria Bioscience Corp. (LEXX) technical indicators as of December 23, 2025: the SMA 20 is -32.81%, SMA 50 at -32.68%, and SMA 200 at -37.4%. The RSI 14 value is 34.97, suggesting its current momentum. These technical analysis signals help assess LEXX's price trends and potential future movements.
Lexaria Bioscience Corp. (LEXX) stock performance overview as of December 23, 2025: The 52-week high is $2.43 (currently -72.26% below), and the 52-week low is $0.48 (currently 40.42% above). Over the past year, LEXX's performance is -68.8%, compared to the S&P 500's 10.56% change.
According to market data, Lexaria Bioscience Corp. (LEXX) stock's recent performance metrics show that over the last month, LEXX is -38.73%, with a Year-to-Date (YTD) performance of -67.9%. Over the past year, the stock has seen a -68.8% change. These figures summarize LEXX's price movements across various periods, reflecting its historical returns.
According to current financial data, LEXX stock's P/E (TTM) ratio is -1.09, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for LEXX, including P/S (19.98), P/B (2.24), and P/FCF (-1.26), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.